-
Third wave of COVID in India likely to peak in early Feb: Study
ExpressPharma
December 28, 2021
The third wave of the COVID-19 pandemic in India may peak by February 3, 2022, claims a modelling study by researchers at Indian Institute of Technology Kanpur.
-
FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults
WorldPharmaNews
December 28, 2021
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck's molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing...
-
Chinese mainland reports 162 locally transmitted COVID-19 cases
NMPA/Xinhua
December 28, 2021
The Chinese mainland on Dec 26 reported 162 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 27.
-
India grants EUA to Bharat Biotech’s Covid-19 vaccine for use in children
Pharmaceutical-Technology
December 28, 2021
The Drug Controller General of India (DGCI) has granted Emergency Use Authorization (EUA) to Bharat Biotech’s Covid-19 vaccine, Covaxin, for use in children aged 12 to 18 years.
-
Depressive Symptoms Increased Among Seniors During COVID-19
drugs
December 28, 2021
During the COVID-19 pandemic, there was an increase in the prevalence of clinically significant depressive symptoms among older adults, according to a study published online Dec. 22 in JAMA Psychiatry.
-
Convidecia? Phase III Results Published in The Lancet
prnasia
December 27, 2021
CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that The Lancet[1] published its Phase III clinical trial results on the safety and efficacy of its Recombinant Novel Coronavirus Vaccine...
-
Evusheld to prevent Covid-19: There won't be nearly enough for Americans who are eligible
FirstWordPharma
December 27, 2021
The US government has only contracted for enough doses of AstraZeneca's Evusheld to cover less than one-tenth the number of people who are eligible for it, reported CNN.
-
Netherlands approves Novavax Covid vaccine; Won't use Janssen boosters
FirstWordPharma
December 27, 2021
The Netherlands has approved the use of Novavax's protein-based COVID-19 vaccine Nuvaxovid, reported NL Times.
-
FDA grants EUA for Merck-Ridgeback’s oral Covid-19 antiviral molnupiravir
Pharmaceutical-Technology
December 27, 2021
The authorisation is based on positive results from the Phase III MOVe-OUT trial of molnupiravir in adult Covid-19 patients.
-
'Breakthrough' COVID Infections Can Still Be Deadly for Cancer Patients
drugs
December 27, 2021
When fully vaccinated cancer patients develop a breakthrough case of COVID-19, most will become seriously ill and end up hospitalized, a new study finds.